Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Fate Therapeutics (NASDAQ:FATE) through any online brokerage.
There are no as such competitors for Fate Therapeutics.
Fate Therapeutics has a consensus price target of $5.91.
The stock price for Fate Therapeutics (NASDAQ: FATE) is $2.8111 last updated May 29, 2026 at 7:51 PM EDT.
There are no upcoming dividends for Fate Therapeutics.
Fate Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Fate Therapeutics.
Fate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.